These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22635102)

  • 1. The metal theory of Alzheimer's disease.
    Bush AI
    J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.
    Duce JA; Tsatsanis A; Cater MA; James SA; Robb E; Wikhe K; Leong SL; Perez K; Johanssen T; Greenough MA; Cho HH; Galatis D; Moir RD; Masters CL; McLean C; Tanzi RE; Cappai R; Barnham KJ; Ciccotosto GD; Rogers JT; Bush AI
    Cell; 2010 Sep; 142(6):857-67. PubMed ID: 20817278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallostasis in Alzheimer's disease.
    Ayton S; Lei P; Bush AI
    Free Radic Biol Med; 2013 Sep; 62():76-89. PubMed ID: 23142767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
    Greenough MA; Camakaris J; Bush AI
    Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metals and Alzheimer's disease.
    Adlard PA; Bush AI
    J Alzheimers Dis; 2006 Nov; 10(2-3):145-63. PubMed ID: 17119284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain.
    Lee JY; Cho E; Kim TY; Kim DK; Palmiter RD; Volitakis I; Kim JS; Bush AI; Koh JY
    Biometals; 2010 Dec; 23(6):1085-95. PubMed ID: 20556483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.
    Greenough MA
    J Mol Neurosci; 2016 Nov; 60(3):289-297. PubMed ID: 27558108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined deletions of amyloid precursor protein and amyloid precursor-like protein 2 reveal different effects on mouse brain metal homeostasis.
    Needham BE; Ciccotosto GD; Cappai R
    Metallomics; 2014 Mar; 6(3):598-603. PubMed ID: 24448592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains.
    Lin CJ; Huang HC; Jiang ZF
    Brain Res Bull; 2010 Jul; 82(5-6):235-42. PubMed ID: 20598459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper and Alzheimer's Disease.
    Mathys ZK; White AR
    Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
    Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
    Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
    Crouch PJ; White AR; Bush AI
    FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
    Lee JY; Friedman JE; Angel I; Kozak A; Koh JY
    Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease.
    Schrag M; Crofton A; Zabel M; Jiffry A; Kirsch D; Dickson A; Mao XW; Vinters HV; Domaille DW; Chang CJ; Kirsch W
    J Alzheimers Dis; 2011; 24(1):137-49. PubMed ID: 21187585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
    Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
    J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper and Alzheimer's disease.
    Donnelly PS; Xiao Z; Wedd AG
    Curr Opin Chem Biol; 2007 Apr; 11(2):128-33. PubMed ID: 17300982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.